HEADER APOPTOSIS/INHIBITOR 29-AUG-19 6U64 TITLE MCL-1 BOUND TO COMPOUND 17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTI-APOPTOTIC, INHIBITOR, PROTEIN BINDING, APOPTOSIS-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.A.STUCKEY REVDAT 3 13-MAR-24 6U64 1 REMARK REVDAT 2 25-MAR-20 6U64 1 JRNL REVDAT 1 04-MAR-20 6U64 0 JRNL AUTH K.J.KUMP,L.MIAO,A.S.A.MADY,N.H.ANSARI,U.K.SHRESTHA,Y.YANG, JRNL AUTH 2 M.PAL,C.LIAO,A.PERDIH,F.A.ABULWERDI,K.CHINNASWAMY, JRNL AUTH 3 J.L.MEAGHER,J.M.CARLSON,M.KHANNA,J.A.STUCKEY, JRNL AUTH 4 Z.NIKOLOVSKA-COLESKA JRNL TITL DISCOVERY AND CHARACTERIZATION OF 2,5-SUBSTITUTED BENZOIC JRNL TITL 2 ACID DUAL INHIBITORS OF THE ANTI-APOPTOTIC MCL-1 AND BFL-1 JRNL TITL 3 PROTEINS. JRNL REF J.MED.CHEM. V. 63 2489 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31971799 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01442 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 5816 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.470 REMARK 3 FREE R VALUE TEST SET COUNT : 260 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.67 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1628 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2162 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1563 REMARK 3 BIN R VALUE (WORKING SET) : 0.2149 REMARK 3 BIN FREE R VALUE : 0.2490 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.99 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 65 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1079 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 78.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 83.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.10480 REMARK 3 B22 (A**2) : 5.10480 REMARK 3 B33 (A**2) : -10.20970 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.448 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.506 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.267 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.616 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.273 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1271 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1784 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 546 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 23 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 277 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1271 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 148 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1455 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.42 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|172 - 320} REMARK 3 ORIGIN FOR THE GROUP (A): -11.4930 -15.0916 -16.4354 REMARK 3 T TENSOR REMARK 3 T11: 0.0491 T22: -0.0882 REMARK 3 T33: -0.2154 T12: -0.2435 REMARK 3 T13: -0.1294 T23: -0.0828 REMARK 3 L TENSOR REMARK 3 L11: 3.6498 L22: 2.9289 REMARK 3 L33: 5.7211 L12: -0.4328 REMARK 3 L13: 0.7733 L23: -0.8315 REMARK 3 S TENSOR REMARK 3 S11: 0.1419 S12: 0.5329 S13: -0.3683 REMARK 3 S21: -0.5669 S22: 0.0246 S23: 0.3149 REMARK 3 S31: 1.2230 S32: -0.7502 S33: -0.1665 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6U64 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1000244028. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96295 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5833 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.540 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 20.90 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 21.50 REMARK 200 R MERGE FOR SHELL (I) : 0.64900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 3350, 0.2 MM MGCL2 AND 0.1 M REMARK 280 ADA PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 55.84000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 32.23924 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 24.11333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 55.84000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 32.23924 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 24.11333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 55.84000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 32.23924 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 24.11333 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 55.84000 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 32.23924 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 24.11333 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 55.84000 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 32.23924 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 24.11333 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 55.84000 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 32.23924 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 24.11333 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 64.47848 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 48.22667 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 64.47848 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 48.22667 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 64.47848 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 48.22667 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 64.47848 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 48.22667 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 64.47848 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 48.22667 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 64.47848 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 48.22667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 171 REMARK 465 LYS A 197 REMARK 465 PRO A 198 REMARK 465 MET A 199 REMARK 465 GLY A 200 REMARK 465 ARG A 201 REMARK 465 SER A 202 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 ARG A 176 CD NE CZ NH1 NH2 REMARK 470 GLU A 180 OE1 OE2 REMARK 470 ARG A 184 NE CZ NH1 NH2 REMARK 470 ALA A 193 CB REMARK 470 LYS A 194 CG CD CE NZ REMARK 470 ASP A 195 CG OD1 OD2 REMARK 470 THR A 196 OG1 CG2 REMARK 470 SER A 206 CB OG REMARK 470 ARG A 207 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 208 CD CE NZ REMARK 470 GLU A 225 CG CD OE1 OE2 REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 ASP A 241 CG OD1 OD2 REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 LEU A 246 CG CD1 CD2 REMARK 470 ARG A 248 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 276 NZ REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 THR A 280 OG1 CG2 REMARK 470 GLU A 284 CD OE1 OE2 REMARK 470 ASP A 296 CG OD1 OD2 REMARK 470 LYS A 308 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 191 -84.87 -94.39 REMARK 500 ALA A 193 -84.86 -156.94 REMARK 500 ASP A 236 -70.00 70.67 REMARK 500 ILE A 237 92.02 46.46 REMARK 500 ASN A 282 -121.09 -131.54 REMARK 500 GLN A 283 -26.10 -148.00 REMARK 500 GLU A 284 -82.50 -167.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 Q0G A 402 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q0G A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q0G A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue Q0G A 403 DBREF 6U64 A 171 320 UNP Q07820 MCL1_HUMAN 171 320 SEQRES 1 A 150 GLU ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SER SEQRES 2 A 150 ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP THR SEQRES 3 A 150 LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS ALA SEQRES 4 A 150 LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN ARG SEQRES 5 A 150 ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS LEU SEQRES 6 A 150 ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER ARG SEQRES 7 A 150 VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN TRP SEQRES 8 A 150 GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE VAL SEQRES 9 A 150 ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER CYS ILE SEQRES 10 A 150 GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL ARG SEQRES 11 A 150 THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP ASP SEQRES 12 A 150 GLY PHE VAL GLU PHE PHE HIS HET Q0G A 401 61 HET Q0G A 402 44 HET Q0G A 403 61 HETNAM Q0G 5-[(2-PHENYLETHYL)SULFANYL]-2-{[(4-PHENYLPIPERAZIN-1- HETNAM 2 Q0G YL)SULFONYL]AMINO}BENZOIC ACID FORMUL 2 Q0G 3(C25 H27 N3 O4 S2) FORMUL 5 HOH *8(H2 O) HELIX 1 AA1 ASP A 172 THR A 191 1 20 HELIX 2 AA2 ALA A 204 HIS A 224 1 21 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 ASP A 256 1 18 HELIX 5 AA5 ASN A 260 ILE A 281 1 22 HELIX 6 AA6 ILE A 287 GLN A 309 1 23 HELIX 7 AA7 ARG A 310 PHE A 319 1 10 CISPEP 1 ALA A 193 LYS A 194 0 -0.23 CISPEP 2 SER A 285 CYS A 286 0 2.02 SITE 1 AC1 10 LEU A 235 VAL A 249 VAL A 253 PHE A 254 SITE 2 AC1 10 ARG A 263 THR A 266 LEU A 267 PHE A 270 SITE 3 AC1 10 Q0G A 402 Q0G A 403 SITE 1 AC2 12 THR A 226 ALA A 227 GLY A 230 ARG A 233 SITE 2 AC2 12 LYS A 234 ASP A 256 GLY A 257 VAL A 258 SITE 3 AC2 12 ARG A 263 THR A 266 Q0G A 401 Q0G A 403 SITE 1 AC3 5 HIS A 224 THR A 226 ALA A 227 Q0G A 401 SITE 2 AC3 5 Q0G A 402 CRYST1 111.680 111.680 72.340 90.00 90.00 120.00 H 3 2 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008954 0.005170 0.000000 0.00000 SCALE2 0.000000 0.010339 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013824 0.00000